NCT07505498 Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set
| NCT ID | NCT07505498 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Medical Center Goettingen |
| Condition | Patient Related Outcome Measures |
| Study Type | OBSERVATIONAL |
| Enrollment | 900 participants |
| Start Date | 2025-12-01 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 900 participants in total. It began in 2025-12-01 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The systematic recording of patient-reported symptoms and health-related quality of life (patient-reported outcomes, PROs) is a central component of oncological care. Currently, however, screening for support needs in German hospitals is inconsistent and uses different assessment tools, leading to heterogeneity, redundant surveys, and limited comparability of results. This complicates standardized, patient-centered, and cross-sector care, as well as the early identification of therapy-associated side effects and support needs. The aim of the study is to investigate the acceptance and relevance of the core set of questions from the perspective of both cancer patients and professional healthcare providers. Cancer patient acceptance will be measured by the proportion of fully completed questionnaires, while cancer patient relevance will be assessed using a feedback form. The professional perspective will be gathered through guided feedback in quality circles conducted regularly in accordance with internal standards
Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * Capacity to give consent * Cancer patients * Sufficient understanding of the German language Exclusion Criteria: * Minors * Lack of capacity to give consent * Insufficient knowledge of German
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07505498 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Patient Related Outcome Measures. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07505498 currently recruiting?
Yes, NCT07505498 is actively recruiting participants. Contact the research team at sabrina.sulzer@med.uni-goettingen.de for enrollment information.
Where is the NCT07505498 trial being conducted?
This trial is being conducted at Göttingen, Germany.
Who is sponsoring the NCT07505498 clinical trial?
NCT07505498 is sponsored by University Medical Center Goettingen. The trial plans to enroll 900 participants.